Schedule 13G ownership disclosure

Coherus Oncology Inc

Common Stock · CUSIP: 19249H103

Event date: 2025-12-31

Filing-level shares
10,028,893
Percent of class
8.29%
  • The Vanguard Group

    Shares: 10,028,893 · Class: 8.29%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-26-000318
Form type
SCHEDULE 13G/A
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Jan 30, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub